Precision treatment for metastatic non-small cell lung cancer: A conceptual overview

Area of Science:

• Oncology
• Genetics
• Molecular Diagnostics

Background:

• Precision oncology has rapidly evolved, increasing the complexity of patient care.
• Diagnostic and therapeutic decisions require sophisticated molecular profiling.

Purpose of the Study:

• To provide a comprehensive review of precision oncology.
• To discuss key mutational drivers in non-small cell lung cancer (NSCLC).
• To correlate these drivers with diagnosis, evaluation, and treatment of metastatic NSCLC.

Main Methods:

• Literature review of precision oncology.
• Analysis of common genetic mutations in NSCLC.
• Correlation of molecular findings with clinical management.

Main Results:

• Precision oncology offers targeted therapeutic strategies.
• Specific mutational drivers in NSCLC impact treatment selection.
• Molecular data is crucial for personalized patient care in metastatic NSCLC.

Conclusions:

• Understanding mutational drivers is essential for effective precision oncology in NSCLC.
• Integrated diagnostic and therapeutic approaches are key for managing metastatic disease.
• Continued research in precision oncology will further refine NSCLC treatment.